Oaktree Acquisition Corp III Life Sciences - Class A OACC Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$10.70 up $0.05, 0.47% at close Oct 16
Last close · Previous close $10.65
- Market cap
- $263.04MAt the Oct 16 close
- P/E ratio
- 36.90On last 12 months’ EPS
- Diluted EPS
- $0.29Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$10.70up $0.05, 0.47%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$10.65Oct 15
- Volume22.25KOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume51.75KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $10.50 to $10.93; now $10.70
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
OACC trailed the S&P 500 in all 4 periods.
| Period | OACC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OACC: down 0.7% S&P 500: up 1.5% | OACC trailed the S&P 500 by 2.2 percentage points Trailed |
| 3M | OACC: unchanged S&P 500: up 1.9% | OACC trailed the S&P 500 by 1.9 percentage points Trailed |
| YTD | OACC: up 1.1% S&P 500: up 12.8% | OACC trailed the S&P 500 by 11.7 percentage points Trailed |
| 1Y | OACC: up 1.8% S&P 500: up 16.8% | OACC trailed the S&P 500 by 15.0 percentage points Trailed |
$10,000 invested in OACC a year ago (Oct 16, 2025) would be worth about $10,181 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,678.
OACC trailed the S&P 500 in all 4 periods.
| Period | OACC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | OACC: down 0.7% S&P 500: up 1.2% | OACC trailed the S&P 500 by 1.9 percentage points Trailed |
| 3M | OACC: unchanged S&P 500: up 1.7% | OACC trailed the S&P 500 by 1.7 percentage points Trailed |
| YTD | OACC: up 1.1% S&P 500: up 11.9% | OACC trailed the S&P 500 by 10.8 percentage points Trailed |
| 1Y | OACC: up 1.8% S&P 500: up 15.5% | OACC trailed the S&P 500 by 13.7 percentage points Trailed |
$10,000 invested in OACC a year ago (Oct 16, 2025) would be worth about $10,181 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $11,553.
All-time high
$10.93
Closing high on . Now 2.1% below that record.
Split-adjusted daily closes since Dec 16, 2024.
Stock splits
OACC hasn’t split since its price history begins in 2024.
Valuation
The Oct 16 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
36.9×The Oct 16 close ÷ diluted EPS over the last 12 months ($0.29)
The range covers daily P/E ratios from Dec 16, 2024 to Oct 16, 2026, each based on the previous 12 months of earnings.
OACC trades at 36.9× its earnings over the last 12 months, below its 5-year median of 37.9×. In plain terms, buyers are paying about $37 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 38.8×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 4.98Last 12 months’ EPS growth
The P/E divided by the growth in diluted EPS over the last 12 months (+7.4% on the 12 months before). It looks backward: near 1 means the P/E roughly matches last year’s growth. Sites that use analysts’ growth forecasts show a different PEG.
PEG = P/E ÷ EPS growth (%) = 36.9 ÷ 7.4 - −0.17%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $261.87MAt the Oct 16 close
What it would cost to buy the whole business: the market cap at the Oct 16 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own OACC DCF in Excel. Value Oaktree Acquisition Corp III Life Sciences with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $0.00
- Net income
- $6.75Mup 38.8%
- Diluted EPS
- $0.29up 7.4%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $0.00 | −$48.10K | −$0.01 |
| Q4 FY24 (Dec 31, 2024) | $0.00 | $1.38M | $0.13 |
| Q1 FY25 (Mar 31, 2025) | $0.00 | $1.66M | $0.07 |
| Q2 FY25 (Jun 30, 2025) | $0.00 | $1.87M | $0.08 |
| Q3 FY25 (Sep 30, 2025) | $0.00 | $1.97M | $0.08 |
| Q4 FY25 (Dec 31, 2025) | $0.00 | $1.79M | $0.08 |
| Q1 FY26 (Mar 31, 2026) | $0.00 | $1.39M | $0.06 |
| Q2 FY26 (Jun 30, 2026) | $0.00 | $1.60M | $0.07 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY24 (Dec 31, 2024) | $0.00 | $1.33M | $0.12 |
| FY25 (Dec 31, 2025) | $0.00 | $7.29M | $0.30 |
Margins
- Gross —
- Operating —
- Net —
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$455.69KLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$455.69KLast 12 months
- Capital spending$0.00Last 12 months
Shareholder returns
- $0.00Last 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
Balance sheet
- $206.46MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$11.82KAs of Jun 30, 2026
- Net cash$206.45MAs of Jun 30, 2026
- 0.73As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio
Financial strength
- 3.3%Last 12 months
Over the last 12 months, Oaktree Acquisition Corp III Life Sciences’s net income was 3.3% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About Oaktree Acquisition Corp III Life Sciences - Class A
Oaktree Acquisition Corp III Life Sciences - Class A
- Sector
- Industrials
- Industry
- Shell Companies
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
OACC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
OACC stock FAQ
What is OACC stock’s price today?
Oaktree Acquisition Corp III Life Sciences (OACC) traded at $10.70 at the close on , up $0.05 (0.47%) from the previous close of $10.65. Over the past 52 weeks it has traded between $10.50 and $10.93.
What is Oaktree Acquisition Corp III Life Sciences’s market cap?
Oaktree Acquisition Corp III Life Sciences’s market capitalization is about $263.0 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $10.70 (how market cap works). Oaktree Acquisition Corp III Life Sciences reported 24.58M shares outstanding at the end of its latest quarter ().
What is OACC’s P/E ratio?
OACC trades at 36.9 times its diluted earnings over the four quarters to ($0.29 per share), at the close. Over the past five years its P/E has ranged from 35.7 to 53.2, with a median of 37.9. (How the P/E ratio works.)
What are OACC’s earnings per share?
OACC’s diluted earnings per share were $0.29 over the four quarters to , compared with $0.27 in the twelve months before. The latest quarter (Q2 FY26) brought $0.07 per share, against $0.08 a year earlier (how EPS works).
Does OACC pay a dividend?
Oaktree Acquisition Corp III Life Sciences hasn’t paid a dividend in the last twelve months.
What is OACC’s 52-week high and low?
Over the past 52 weeks OACC has traded as low as $10.50 and as high as $10.93. At $10.70 at the close on , it is 2.1% below that high and 1.9% above the low.
What is OACC’s all-time high?
OACC’s highest closing price was $10.93 on , adjusted for stock splits. At $10.70 at the close on , it is 2.1% below that record.
Has OACC stock ever split?
No. OACC hasn’t split since its price history begins in 2024.
How has OACC stock performed?
Including dividends and measured to the close on , OACC has returned +1.1% so far this year and +1.8% over the past year. Over the same periods the S&P 500, measured by SPY, returned +12.8% and +16.8%. Past performance doesn’t predict future returns.
What sector and industry is Oaktree Acquisition Corp III Life Sciences in?
Oaktree Acquisition Corp III Life Sciences is in the Industrials sector and the Shell Companies industry, and is headquartered in California, USA.
What exchange does OACC trade on?
Oaktree Acquisition Corp III Life Sciences trades on the Nasdaq under the ticker symbol OACC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.